XML 33 R16.htm IDEA: XBRL DOCUMENT v3.24.1
Note 8 - Options
12 Months Ended
Dec. 31, 2023
Notes  
Note 8 - Options

Note 8 – Options

 

The Company has stock option plans which authorize the grant of stock options to eligible employees, directors and other individuals to purchase up to an aggregate of 285 thousand shares of common stock, of which 84 thousand are outstanding as of December 31, 2023.  All options granted under the plans are granted at current market value at the date of grant, and may be exercised between six months and ten years following the date of grant.  The plans are intended to advance the interest of the Company by attracting and ensuring retention of competent directors, employees and executive personnel, and to provide incentives to those individuals to devote their utmost efforts to the advancement of stockholder value.  Changes in stock options were as follows:

 

 

 

Shares
(000’s)

 

 

Price Range
Per Share

2023

 

 

 

 

 

Granted

 

19

 

$

77.07 - 77.07

Expired or canceled

 

0.4

 

 

77.05 - 77.05

Exercised

 

2

 

 

49.18 - 77.05

Total outstanding at December 31

 

84

 

 

49.18 - 82.60

Total exercisable at December 31

 

50

 

 

49.18 - 82.60

 

 

 

Shares
(000’s)

 

 

Price Range
Per Share

2022

 

 

 

 

 

Granted

 

21

 

$

82.60 - 82.60

Expired or canceled

 

2

 

 

33.30 - 77.05

Exercised

 

4

 

 

33.30 - 77.05

Total outstanding at December 31

 

67

 

 

33.30 - 77.05

Total exercisable at December 31

 

40

 

 

33.30 - 77.05

 

 

 

Shares
(000’s)

 

 

Price Range
Per Share

2021

 

 

 

 

 

Granted

 

-

 

$

- - -

Expired or canceled

 

3

 

 

74.64 - 77.05

Exercised

 

14

 

 

26.52 - 77.05

Total outstanding at December 31

 

52

 

 

33.30 - 77.05

Total exercisable at December 31

 

34

 

 

33.30 - 77.05

 

 

For the years ended December 31, 2023, 2022 and 2021, the Company reduced current income taxes payable by $12, $6 and $39, respectively, for the income tax benefit attributable to sale by optionees of common stock received upon the exercise of stock options.

 

Stock-Based Compensation

 

In 2023, the Company recognized $225 in equity compensation cost, compared to $183 in 2022 and $166 in 2021.  

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 

 

 

Years ended December 31,

 

 

2023

 

 

2022

 

 

2021

Expected dividend amount per quarter

$

0.3090

 

$

0.3050

 

$

-

Expected stock price volatility

 

31.67%

 

 

29.87%

 

 

-

Risk-free interest rate

 

4.75%

 

 

4.09%

 

 

-

Expected life of options

 

5.6 years

 

 

5.7 years

 

 

-

 

 

 

The per share weighted average fair value of options granted during 2023 is $25.09 and in 2022 is $25.34. No options were granted in 2021.

 

All UTMD options vest over a four-year service period.  At December 31, 2023 there was $702 total unrecognized compensation expense related to non-vested stock options under the plans. A $225 portion of the cost is expected to be recognized over the next twelve months, and the remaining $477 recognized over the next 4 years. Expected dividend amounts were estimated based on the actual cash dividend rate at the time the options were granted and an estimate of future dividends based on past dividend rate changes as well as management’s expectations of future dividend rates over the expected holding period of the options.  Expected volatility is based on UTMD’s historical volatility over recent periods of time and trends in that volatility, giving weight to more recent periods.  Risk free interest rates were estimated based on actual U.S. Treasury Securities Interest rates as reported by the Federal Reserve Bank for periods of time equivalent to the holding periods estimated for the options on the dates the options were granted.  Expected term of options were estimated based on historical holding periods for similar options previously granted by UTMD to employees and directors.  

 

The following table summarizes information about stock options outstanding at December 31, 2023:

 

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

 

Actual Number Outstanding

 

Weighted Average Remaining Contractual Life (Years)

 

 

Weighted Average Exercise Price

 

 

Number Exercisable

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

49.18

-

74.64

 

 

23,841

 

3.18

 

$

63.44

 

 

23,841

 

$

63.44

 

77.05

-

82.60

 

 

60,460

 

8.22

 

 

78.95

 

 

24,644

 

 

78.21

$

49.18

-

82.60

 

 

84,301

 

6.79

 

$

74.56

 

 

48,485

 

$

70.95

 

 

 

 

 

 

2023

 

 

2022

 

 

2021

Intrinsic Value of Stock Options Exercised

$

31

 

$

141

 

$

591

Intrinsic Value of Stock Options Outstanding

$

814

 

$

1,812

 

$

1,595